Drug Pipeline

Pevifoscorvir Sodium (ALG-000184) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06963710 A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir… Chronic Hepatitis B Infection Recruiting
Phase 1
NCT07342868 Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of… Chronic Hepaititis B Infections Recruiting
NCT07342881 Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of… Chronic Hepatitis B Infection Recruiting
Sponsors Running Pevifoscorvir Sodium (ALG-000184) Trials
Aligos Therapeutics (3)
Get alerts when Pevifoscorvir Sodium (ALG-000184) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free